Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.


INTRODUCTION The use of radiotherapy plus temozolomide administered concomitantly with and after radiotherapy for glioblastoma was recently shown to improve median and 2-year survival in a large international multicenter study. To compare this result in routine clinical practice, an audit of the management and outcome of patients with glioblastoma at our… (More)
DOI: 10.1016/j.clineuro.2009.06.013


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.


Citations per Year

172 Citations

Semantic Scholar estimates that this publication has 172 citations based on the available data.

See our FAQ for additional information.